Thyme Companies $125 million Series E financing
We advised Morgan Health as lead investor on the financing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Coherus Oncology $50 million at-the-market offering
We advised the sales agent on the offering
Moderna $3 billion convertible notes offering and capped call transactions
We advised the initial purchasers on the offering
Jazz Pharmaceuticals $1.25 billion exchangeable senior notes offering
We advised the initial purchasers on the offering
JATT III Acquisition Corp $69 million SPAC IPO
We advised the sole bookrunning manager on the IPO
Immatics $172.5 million follow-on offering
We advised Immatics on the offering
Aveanna $203 million secondary offering
We advised the underwriters on the offering
Oruka Therapeutics $500 million at-the-market offering
We advised Oruka on the offering
AbbVie $10 billion senior notes offering
We advised the underwriters on the offering
Illumina $300 million notes offering
We advised the underwriters on the offering